Literature DB >> 16344064

Nitric oxide not carbon monoxide mediates nonadrenergic noncholinergic relaxation in the murine internal anal sphincter.

Satish Rattan1, Raymond F Regan, Chirag A Patel, Márcio A F De Godoy.   

Abstract

BACKGROUND & AIMS: Inhibitory reflexes in the internal anal sphincter (IAS) are controlled by inhibitory nonadrenergic, noncholinergic innervation (i-NANC). We investigated the roles of 3 different neurohumoral agonists as possible i-NANC neurotransmitters: carbon monoxide (CO), nitric oxide (NO), and vasoactive intestinal peptide (VIP).
METHODS: IAS smooth muscle strips were isolated from wild-type (WT), heme oxygenase (HO)-2 knockout (HO-2-/-) and neuronal NO synthase (nNOS) knockout (nNOS-/-) mice. Relaxation of IAS was induced by CO, NO, VIP, and electrical field stimulation (EFS) in the presence and absence of neurohumoral inhibitors (tin protoporphyrin IX [SnPP IX] for CO synthesis, N(omega)-nitro-L-arginine [L-NNA] for NO synthesis, and VIP(10-28) for VIP receptor). Western blot and immunohistochemistry were used to test the presence and localization of HO (for CO synthesis) types 1 (HO-1) and 2 (HO-2), neuronal NO synthase (nNOS, for NO synthesis), and VIP.
RESULTS: All 3 neurohumoral agonists produced relaxation (with no difference between WT and HO-2-/- IAS), but CO was over 100 times less potent than NO and VIP. EFS produced relaxation in WT and HO-2-/- IAS with the same intensity. L-NNA and nNOS deletion (approximately 80%) and VIP(10-28) (approximately 15%) significantly inhibited the relaxations, whereas SnPP IX had no effect. Positive immunoreactivities for HO-2, nNOS, and VIP were found in the myenteric plexus of WT IAS. HO-2-/- IAS did not express immunoreactivity for HO-2.
CONCLUSIONS: i-NANC relaxations of mouse IAS are primarily mediated via NO (by nNOS activity) and partly via VIP. CO directly relaxes the mouse IAS but does not play any significant role in the i-NANC relaxation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16344064     DOI: 10.1053/j.gastro.2005.08.050

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  15 in total

1.  Changes in neuromuscular transmission in the W/W(v) mouse internal anal sphincter.

Authors:  A M Duffy; C A Cobine; K D Keef
Journal:  Neurogastroenterol Motil       Date:  2011-11-10       Impact factor: 3.598

Review 2.  Review article: carbon monoxide in gastrointestinal physiology and its potential in therapeutics.

Authors:  S J Gibbons; P-J Verhulst; A Bharucha; G Farrugia
Journal:  Aliment Pharmacol Ther       Date:  2013-08-28       Impact factor: 8.171

Review 3.  A review of chronic anal fissure management.

Authors:  E E Collins; J N Lund
Journal:  Tech Coloproctol       Date:  2007-08-03       Impact factor: 3.781

4.  Comparison of inhibitory neuromuscular transmission in the Cynomolgus monkey IAS and rectum: special emphasis on differences in purinergic transmission.

Authors:  C A Cobine; M McKechnie; R J Brookfield; K I Hannigan; K D Keef
Journal:  J Physiol       Date:  2018-10-13       Impact factor: 5.182

5.  BDNF augments rat internal anal sphincter smooth muscle tone via RhoA/ROCK signaling and nonadrenergic noncholinergic relaxation via increased NO release.

Authors:  Arjun Singh; Ipsita Mohanty; Jagmohan Singh; Satish Rattan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-11-04       Impact factor: 4.052

6.  Role of SM22 in the differential regulation of phasic vs. tonic smooth muscle.

Authors:  Satish Rattan; Mehboob Ali
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-01-23       Impact factor: 4.052

7.  Functional role of vasoactive intestinal polypeptide in inhibitory motor innervation in the mouse internal anal sphincter.

Authors:  K D Keef; S N Saxton; R A McDowall; R E Kaminski; A M Duffy; C A Cobine
Journal:  J Physiol       Date:  2013-01-21       Impact factor: 5.182

8.  Locality-dependent descending reflex motor activity in the anal canal--cholinergic and nitrergic contributions in the rat model.

Authors:  Radomir Radomirov; Christina Ivancheva; Dimitar Itzev; Polina Petkova-Kirova
Journal:  Acta Pharmacol Sin       Date:  2009-08-24       Impact factor: 6.150

9.  Clinical trial: effects of botulinum toxin on Levator ani syndrome--a double-blind, placebo-controlled study.

Authors:  S S C Rao; J Paulson; M Mata; B Zimmerman
Journal:  Aliment Pharmacol Ther       Date:  2009-02-13       Impact factor: 8.171

10.  3-Hydroxymethyl coenzyme A reductase inhibition attenuates spontaneous smooth muscle tone via RhoA/ROCK pathway regulated by RhoA prenylation.

Authors:  Satish Rattan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-04-08       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.